🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
This study will test the effect of four common oral anti-diabetic agents on...
Status
Unknown
Location
Oslo University Hospital, Aker Hospital
Start Date
2021-02-10
Trial ID
NCT04662866
The purpose of this study is to evaluate the efficacy and safety of Madalen...
Status
Recruiting
Location
EMS
Start Date
2024-11-18
Trial ID
NCT04670666
The objective of the study is to investigate the efficacy, safety and toler...
Status
Completed
Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Start Date
2013-01
Trial ID
NCT01778049
Two independent study parts (i.e. Part A and Part B) are included in this t...
Status
Completed
Location
Tokai Memorial Hospital
Start Date
2015-05-12
Trial ID
NCT02489968
This trial will evaluate use of BI 10773/linagliptin once daily (qd) fixed ...
Status
Completed
Location
1275.1.01103 Boehringer Ingelheim Investigational Site
Start Date
2011-08
Trial ID
NCT01422876
Treatments Being Tested
The primary aim of this exploratory mechanistic study is to investigate the...
Status
Completed
Location
Profil Mainz GmbH & Co. KG
Start Date
2015-05
Trial ID
NCT02401880
Treatments Being Tested
This trial compare the use of two different doses of Empagliflozin to place...
Status
Completed
Location
1275.9.01013 Boehringer Ingelheim Investigational Site
Start Date
2013-02-08
Trial ID
NCT01734785
In normal physiology, glucagon from pancreatic alpha cells plays an importa...
Status
Completed
Location
Center for Diabetes Research, Gentofte Hospital, Copenhagen University
Start Date
2016-05
Trial ID
NCT02792400
This trial will compare the use of fixed dose combination of empagliflozin ...
Status
Completed
Location
Nagoya Kyoritsu Hospital
Start Date
2015-05-14
Trial ID
NCT02453555